"glycoengineered" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "glyco",
        "3": "engineered"
      },
      "expansion": "glyco- + engineered",
      "name": "prefix"
    }
  ],
  "etymology_text": "From glyco- + engineered.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "glycoengineered (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with glyco-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2014 May 19, Juergen M. Schanzer et al., “A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties*”, in The Journal of Biological Chemistry, volume 289, →DOI:",
          "text": "To further increase immune effector functions triggered by XGFR, the Fc portion of the bispecific antibody was glycoengineered, which resulted in strong antibody-dependent cell-mediated cytotoxicity activity.",
          "type": "quote"
        }
      ],
      "glosses": [
        "Modified by glycoengineering"
      ],
      "id": "en-glycoengineered-en-adj-X551pu3V",
      "links": [
        [
          "glycoengineering",
          "glycoengineering"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "glycoengineered"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "glyco",
        "3": "engineered"
      },
      "expansion": "glyco- + engineered",
      "name": "prefix"
    }
  ],
  "etymology_text": "From glyco- + engineered.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "glycoengineered (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with glyco-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2014 May 19, Juergen M. Schanzer et al., “A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties*”, in The Journal of Biological Chemistry, volume 289, →DOI:",
          "text": "To further increase immune effector functions triggered by XGFR, the Fc portion of the bispecific antibody was glycoengineered, which resulted in strong antibody-dependent cell-mediated cytotoxicity activity.",
          "type": "quote"
        }
      ],
      "glosses": [
        "Modified by glycoengineering"
      ],
      "links": [
        [
          "glycoengineering",
          "glycoengineering"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "glycoengineered"
}